Drug profile · INN
aclidinium bromide
BRETARIS GENUAIR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
aclidinium bromide (BRETARIS GENUAIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
INN aclidinium bromide
Brand BRETARIS GENUAIR
Route INHALATION
Formulation POWDER, METERED
ATC code R03BB
Frequently asked questions
What is aclidinium bromide?
aclidinium bromide (BRETARIS GENUAIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for aclidinium bromide?
BRETARIS GENUAIR is a marketed brand name for aclidinium bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aclidinium bromide?
aclidinium bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.